This chapter explores the transformative impact of generative AI on internet operations and business strategies, using Intel's AI accelerators as a case study with Netflix. It also examines the competition in the GLP-1 drug market, particularly Eli Lilly's advancements and their implications for market share and revenue.
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Madison Muller, Bloomberg Health Reporter, on Eli Lilly earnings and her Big Take: What It’s Like When Ozempic Takes Over an Entire Town. Kevin Near, Bloomberg Intelligence Senior Media Associate Analyst, on Warner-Discovery Earnings/Paramount before earnings. Greg Petro, CEO of First Insight, on the role of social media, its biasness in guiding decision-making for consumers. And we Drive to the Close with Jayson Bronchetti, CIO at Lincoln Financial
Hosts: Carol Massar and Matt Miller. Producer: Paul Brennan and Sebastian Escobar
See omnystudio.com/listener for privacy information.